Protagonist Therapeutics Inc.
PTGX | NASDAQ
$145.84
+$0.86 (+0.59%)
Sep 22, 2026, 10:33 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 281.99M | 74.06M | 46.02M | 209.22M | 209.18M | 207.8M | 434.43M | 323.8M | 319.12M | 314.95M | 60M | n/a | n/a | 859K | 26.58M | 35.2M | 45.48M | 46.89M | 27.36M | 24.39M | 27.22M | 31.17M |
Cost of Revenue | 407K | 407K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 843K | 1.68M | 2.5M | 2.5M | 1.65M | 819K | n/a | n/a | n/a |
Gross Profit | 281.59M | 73.66M | 46.02M | 209.22M | 209.18M | 207.8M | 434.43M | 323.8M | 319.12M | 314.95M | 60M | n/a | n/a | 16K | 24.91M | 32.7M | 42.99M | 45.24M | 26.54M | 24.39M | 27.22M | 31.17M |
Operating Income | 58.34M | -142.47M | -158.13M | 19.01M | 23.98M | 27.22M | 252.84M | 149.11M | 152.24M | 148.68M | -93.65M | -153.22M | -147.19M | -146.28M | -131.37M | -132.77M | -134.4M | -123.84M | -126.75M | -107.66M | -81.51M | -68.84M |
Interest Income | 26.12M | 27.09M | 28.79M | 28.88M | 29.51M | 29.51M | 26.32M | 23.7M | 20.27M | 16.78M | 14.9M | 12.91M | 9.81M | 6.38M | 4.06M | 1.93M | 896K | 509K | 443K | 401K | 366K | 476K |
Pretax Income | 84.34M | -115.38M | -129.31M | 48.07M | 53.78M | 57.09M | 279.41M | 173.08M | 172.6M | 165.44M | -78.96M | -140.48M | -137.61M | -140.19M | -127.39M | -131.01M | -133.58M | -123.38M | -126.45M | -107.53M | -81.49M | -68.94M |
Net Income | 82.91M | -114.71M | -130.15M | 45.91M | 52.04M | 56.19M | 275.19M | 170.85M | 169.95M | 162.11M | -78.96M | -140.48M | -137.61M | -140.19M | -127.39M | -130.11M | -132.68M | -122.48M | -125.55M | -107.53M | -81.49M | -70.07M |
Selling & General & Admin | 48.49M | 46.39M | 44.85M | 42.37M | 41.4M | 40.29M | 43.46M | 42.56M | 40.06M | 39.8M | 33.49M | 32.07M | 31.31M | 28.99M | 30.06M | 29.87M | 30.23M | 30.09M | 26.38M | 24.93M | 22.57M | 20.03M |
Research & Development | 175.16M | 170.14M | 159.29M | 147.84M | 143.8M | 140.29M | 138.13M | 132.12M | 126.82M | 126.48M | 120.16M | 121.15M | 115.88M | 117.31M | 126.22M | 135.6M | 147.16M | 139.96M | 128.72M | 109.57M | 88.61M | 81.45M |
Other Expenses | -407K | -407K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -985K | -1.81M | -2.45M | -2.51M | -1.53M |
Operating Expenses | 223.24M | 216.12M | 204.14M | 190.21M | 185.2M | 180.58M | 181.59M | 174.68M | 166.88M | 166.28M | 153.65M | 153.22M | 147.19M | 146.3M | 156.28M | 165.48M | 177.39M | 169.07M | 153.28M | 132.05M | 108.72M | 100.01M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 127K | 146K | 355K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 223.65M | 216.53M | 204.14M | 190.21M | 185.2M | 180.58M | 181.59M | 174.68M | 166.88M | 166.28M | 153.65M | 153.22M | 147.19M | 147.14M | 157.95M | 167.97M | 179.88M | 170.73M | 154.1M | 132.05M | 108.72M | 100.01M |
Income Tax Expense | 1.43M | -664K | 838K | 2.16M | 1.74M | 894K | 4.22M | 2.23M | 2.65M | 3.33M | n/a | n/a | n/a | n/a | n/a | -900K | -900K | -900K | -900K | n/a | n/a | 1.13M |
Shares Outstanding (Basic) | 65.94M | 65.09M | 63.57M | 63.77M | 63.51M | 62.96M | 62.33M | 61.77M | 61.31M | 60.86M | 60.39M | 59.18M | 56.78M | 50.57M | 49.26M | 48.8M | 48.85M | 48.67M | 48.15M | 47.99M | 44.86M | 44.22M |
Shares Outstanding (Diluted) | 71.01M | 70.49M | 63.57M | 63.77M | 63.51M | 62.96M | 66.41M | 61.77M | 61.31M | 63.6M | 61.8M | 59.18M | 56.78M | 50.57M | 49.26M | 49.11M | 49.05M | 48.75M | 48.15M | 47.99M | 44.86M | 44.22M |
EPS (Basic) | 1.22 | -1.80 | -2.05 | 0.75 | 0.83 | 0.88 | 4.48 | 2.82 | 2.78 | 2.60 | -1.43 | -2.52 | -2.56 | -2.71 | -2.52 | -2.65 | -2.73 | -2.59 | -2.70 | -2.41 | -1.92 | -1.82 |
EPS (Diluted) | 1.03 | -1.81 | -2.05 | 0.62 | 0.70 | 0.75 | 4.20 | 2.66 | 2.62 | 2.44 | -1.44 | -2.52 | -2.55 | -2.70 | -2.51 | -2.64 | -2.73 | -2.59 | -2.70 | -2.41 | -1.92 | -1.82 |
EBITDA | 85.48M | -113.93M | -128.03M | 49.51M | 55.51M | 59.99M | 282.3M | 176.27M | 175.98M | 168.15M | -75.64M | -135.51M | -132.61M | -135.16M | -122.37M | -127.66M | -130.38M | -120.84M | -124.59M | -106.08M | -80.13M | -66.91M |
EBIT | 84.34M | -115.38M | -129.31M | 48.07M | 53.78M | 57.09M | 279.41M | 173.08M | 172.6M | 165.44M | -78.96M | -138.83M | -135.95M | -138.53M | -125.74M | -131.01M | -133.58M | -123.38M | -126.47M | -107.5M | -81.47M | -68.71M |
Depreciation & Amortization | 1.14M | 1.45M | 1.28M | 1.44M | 1.73M | 2.9M | 2.9M | 3.19M | 3.37M | 2.72M | 3.31M | 3.32M | 3.35M | 3.37M | 3.37M | 3.35M | 3.2M | 2.54M | 1.89M | 1.42M | 1.34M | 1.8M |
Add to Watchlist
Select watchlists to add or remove PTGX